the data were then reanalyzed to detect possible differences in efficacy of loxapine versus the reference compounds in those patients with a clinical diagnosis of schizophrenia , paranoid type and in those patients of any diagnostic subtype other than paranoid .
C0024056
loxapine
C0036341
schizophrenia